Literature DB >> 26510734

Proteomics in the genome engineering era.

Giel Vandemoortele1,2, Kris Gevaert1,2, Sven Eyckerman1,2.   

Abstract

Genome engineering experiments used to be lengthy, inefficient, and often expensive, preventing a widespread adoption of such experiments for the full assessment of endogenous protein functions. With the revolutionary clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 technology, genome engineering became accessible to the broad life sciences community and is now implemented in several research areas. One particular field that can benefit significantly from this evolution is proteomics where a substantial impact on experimental design and general proteome biology can be expected. In this review, we describe the main applications of genome engineering in proteomics, including the use of engineered disease models and endogenous epitope tagging. In addition, we provide an overview on current literature and highlight important considerations when launching genome engineering technologies in proteomics workflows.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Disease models; Epitope tagging; Genome engineering; Knock-out studies; Structure-function studies; Technology

Mesh:

Substances:

Year:  2015        PMID: 26510734     DOI: 10.1002/pmic.201500262

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  2 in total

Review 1.  Applications of CRISPR-Cas Technologies to Proteomics.

Authors:  Georgii Dolgalev; Ekaterina Poverennaya
Journal:  Genes (Basel)       Date:  2021-11-12       Impact factor: 4.096

2.  An extra dimension in protein tagging by quantifying universal proteotypic peptides using targeted proteomics.

Authors:  Giel Vandemoortele; An Staes; Giulia Gonnelli; Noortje Samyn; Delphine De Sutter; Elien Vandermarliere; Evy Timmerman; Kris Gevaert; Lennart Martens; Sven Eyckerman
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.